Skip to main content

Articles

Page 227 of 376

  1. The purpose of this analysis was to determine the potential efficacy of recombinant human tissue factor pathway inhibitor (tifacogin) in a subpopulation of patients with community-acquired pneumonia (CAP) from...

    Authors: Pierre-François Laterre, Steven M Opal, Edward Abraham, Steven P LaRosa, Abla A Creasey, Fang Xie, Lona Poole and Richard G Wunderink
    Citation: Critical Care 2009 13:R36